Your browser doesn't support javascript.
loading
Phase II DeCOG-study of ipilimumab in pretreated and treatment-naïve patients with metastatic uveal melanoma.
Zimmer, Lisa; Vaubel, Julia; Mohr, Peter; Hauschild, Axel; Utikal, Jochen; Simon, Jan; Garbe, Claus; Herbst, Rudolf; Enk, Alexander; Kämpgen, Eckhart; Livingstone, Elisabeth; Bluhm, Leonie; Rompel, Rainer; Griewank, Klaus G; Fluck, Michael; Schilling, Bastian; Schadendorf, Dirk.
Afiliação
  • Zimmer L; Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany.
  • Vaubel J; Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany.
  • Mohr P; Department of Dermatology, Buxtehude, Germany.
  • Hauschild A; University Department of Dermatology, Kiel, Germany.
  • Utikal J; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, Ruprecht-Karl University of Heidelberg, Mannheim, Germany.
  • Simon J; University Department of Dermatology, Leipzig, Germany.
  • Garbe C; University Department of Dermatology, Tübingen, Germany.
  • Herbst R; Department of Dermatology, Erfurt, Germany.
  • Enk A; Department of Dermatology, University Hospital, Ruprecht-Karl University of Heidelberg, Heidelberg, Germany.
  • Kämpgen E; Department of Dermatology, University Hospital, Erlangen, Germany.
  • Livingstone E; Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany.
  • Bluhm L; Department of Dermatology, Buxtehude, Germany.
  • Rompel R; Department of Dermatology, Kassel, Germany.
  • Griewank KG; Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany.
  • Fluck M; Department of Dermatology Hornheide, Münster, Germany.
  • Schilling B; Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany.
  • Schadendorf D; Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany.
PLoS One ; 10(3): e0118564, 2015.
Article em En | MEDLINE | ID: mdl-25761109
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Uveais / Melanoma / Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: PLoS One Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Uveais / Melanoma / Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: PLoS One Ano de publicação: 2015 Tipo de documento: Article